Intrinsiqq
Cardinal Health Inc. logo

Cardinal Health Inc. (CAH) Insider Trading

Last 12 months

Insiders sold $61.6M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Executive Officer Jason M. Hollar sold $29.4M on Aug 19, 40% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2022.

Net open-market
−$61.6M
0 buys · 10 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 8
executives and directors
Last open-market buy
Nov 2022
Nov 15, 2022

Get an email when CAH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 19No plan
    Mary C. Scherer
    Chief Accounting Officer · sold 2,302 at avg $237.39
    $546k
    45% of stake
  • Aug 18 – 19No plan
    Jason M. Hollar
    Chief Executive Officer · sold 124,529 at avg $235.89
    $29.4M
    40% of stake
  • Aug 18No plan
    Michelle D. Greene
    Chief Information Officer · sold 11,650 at avg $235.72
    $2.75M
    53% of stake
  • Aug 18No plan
    Deborah Weitzman
    CEO, PSS Segment · sold 7,354 at avg $235.45
    $1.73M
    8.6% of stake
  • Aug 18No plan
    Stephen M Mason
    CEO, GMPD Segment · sold 35,000 at avg $236.40
    $8.27M
    66% of stake
  • Aug 18No plan
    Jessica L Mayer
    Chief Legal/Compliance Officer · sold 29,436 at avg $236.19
    $6.95M
    47% of stake
  • Aug 18No plan
    Aaron E Alt
    Chief Financial Officer · sold 42,000 at avg $236.34
    $9.93M
    67% of stake
  • Feb 27No plan
    Michelle D. Greene
    Chief Information Officer · sold 2,746 at avg $228.47
    $627k
    18% of stake
  • Feb 18No plan
    Aaron E Alt
    Chief Financial Officer · sold 2,328 at $225.50
    $525k
    8.1% of stake
  • Feb 6No plan
    Patricia Hemingway Hall
    Director · sold 4,000 at $229.72
    $919k
    12% of stake
  • Aug 20, 2025No plan
    Deborah Weitzman
    CEO, PSS Segment · sold 21,367 at $150.53
    $3.22M
    29% of stake
  • Aug 20, 2025No plan
    Jason M. Hollar
    Chief Executive Officer · sold 35,901 at avg $150.04
    $5.39M
    15% of stake
  • Aug 19, 2025No plan
    Mary C. Scherer
    Chief Accounting Officer · sold 6,766 at $149.25
    $1.01M
    66% of stake
  • Aug 19, 2025No plan
    Michelle D. Greene
    Chief Information Officer · sold 13,500 at avg $148.82
    $2.01M
    47% of stake
  • Aug 19, 2025No plan
    Stephen M Mason
    CEO, GMPD Segment · sold 41,575 at avg $148.82
    $6.19M
    61% of stake
  • Aug 19, 2025No plan
    Jason M. Hollar
    Chief Executive Officer · sold 107,705 at avg $148.90
    $16M
    31% of stake
  • Aug 19, 2025No plan
    Jessica L Mayer
    Chief Legal/Compliance Officer · sold 38,078 at avg $148.82
    $5.67M
    44% of stake
  • Aug 19, 2025No plan
    Aaron E Alt
    Chief Financial Officer · sold 48,243 at avg $148.78
    $7.18M
    61% of stake
  • Aug 19, 2025No plan
    Ola M Snow
    Chief Human Resources Officer · sold 28,151 at avg $148.94
    $4.19M
    64% of stake
  • Nov 14, 2024No plan
    Mary C. Scherer
    Chief Accounting Officer · sold 3,504 at $123.55
    $433k
    29% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CAH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Spot a number that looks wrong? Check it in CAH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CAH

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.